TargetMol

1-O-Hexadecyl-2-lyso-glycero-3-phosphorylcholine

Product Code:
 
TAR-T29308
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T29308-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29308-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
1-O-Hexadecyl-2-lyso-glycero-3-phosphorylcholine is a biologically inactive precursor of platelet activating factor.
CAS:
52691-62-0
Molecular Weight:
481.65
Purity:
0.98
SMILES:
O(C[C@@H](COCCCCCCCCCCCCCCCC)O)P(OCC[N+](C)(C)C)(=O)[O-]

References

Qian CG, Lee TC, Snyder F. Metabolism of platelet activating factor (PAF) and related ether lipids by neonatal rat myocytes. J Lipid Mediat. 1989 Mar-Apr;1(2):113-23. PubMed PMID: 2519887. Li Y, Hou M, Wang JG, Wang T, Wan J, Jiao BH, Lin ZF. Changes of lymph metabolites in a rat model of sepsis induced by cecal ligation and puncture. J Trauma Acute Care Surg. 2012 Dec;73(6):1545-52. doi: 10.1097/TA.0b013e31826fc9e7. PubMed PMID: 23147180. Mickelson JK, Simpson PJ, Lucchesi BR. Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. J Mol Cell Cardiol. 1988 Jun;20(6):547-61. PubMed PMID: 3216407.